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Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a severe X-linked
neurodevelopmental encephalopathy caused by mutations in the CDKL5 gene and
characterized by early-onset epilepsy and intellectual and motor impairments. No cure
is currently available for CDD patients, as limited knowledge of the pathology has
hindered the development of therapeutics. Cdkl5 knockout (KO) mouse models, recently
created to investigate the role of CDKL5 in the etiology of CDD, recapitulate various
features of the disorder. Previous studies have shown alterations in synaptic plasticity
and dendritic pattern in the cerebral cortex and in the hippocampus, but the knowledge
of the molecular substrates underlying these alterations is still limited. Here, we have
examined for the first time synaptic function and plasticity, dendritic morphology, and
signal transduction pathways in the perirhinal cortex (PRC) of this mouse model.
Being interconnected with a wide range of cortical and subcortical structures and
involved in various cognitive processes, PRC provides a very interesting framework
for examining how CDKL5 mutation leads to deficits at the synapse, circuit, and
behavioral level. We found that long-term potentiation (LTP) was impaired, and that the
TrkB/PLCγ1 pathway could be mechanistically involved in this alteration. PRC neurons
in mutant mice showed a reduction in dendritic length, dendritic branches, PSD-95-
positive puncta, GluA2-AMPA receptor levels, and spine density and maturation. These
functional and structural deficits were associated with impairment in visual recognition
memory. Interestingly, an in vivo treatment with a TrkB agonist (the 7,8-DHF prodrug
R13) to trigger the TrkB/PLCγ1 pathway rescued defective LTP, dendritic pattern,
PSD-95 and GluA2-AMPA receptor levels, and restored visual recognition memory in
Cdkl5 KO mice. Present findings demonstrate a critical role of TrkB signaling in the
synaptic development alterations due to CDKL5 mutation, and suggest the possibility
of TrkB-targeted pharmacological interventions.
Keywords: CDKL5, synaptic plasticity, TrkB, PLCγ1, dendritic pattern, GluA2, perirhinal cortex, rett syndrome
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INTRODUCTION
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder
(CDD) is a rare encephalopathy characterized by early-onset
intractable epileptic seizures, severe intellectual disability, gross
motor impairment, stereotypies, visual impairments and autistic-
like features (Kalscheuer et al., 2003; Weaving et al., 2004; Bahi-
Buisson et al., 2008; Bahi-Buisson and Bienvenu, 2012; Moseley
et al., 2012; Paine et al., 2012; Stalpers et al., 2012; Fehr et al.,
2013). CDD is caused by mutations in the X-linked gene, CDKL5,
a member of a highly conserved family of serine-threonine
kinases (Tao et al., 2004). To date, several different mutations
have been described in the CDKL5 gene, mainly located within
the CDKL5 catalytic domain (Kilstrup-Nielsen et al., 2012; Das
et al., 2013; Fehr et al., 2013), suggesting that impaired CDKL5
kinase activity plays an important role in the pathogenesis of
CDD (Tao et al., 2004; Bahi-Buisson et al., 2012).
No cure is currently available for CDD patients, as limited
knowledge of the pathology has hindered the development of
therapeutics. Cdkl5 knockout (KO) mice (Wang et al., 2012;
Amendola et al., 2014; Okuda et al., 2017) have recently
been created to investigate the role of CDKL5 in the etiology
of CDD. Cdkl5 KO mice recapitulate different features of
CDD, exhibiting severe impairment in learning and memory,
visual and respiratory deficits, and motor stereotypies (Wang
et al., 2012; Amendola et al., 2014; Fuchs et al., 2014, 2015;
Mazziotti et al., 2017). The neuropathology of CDD points to
arrested neuronal development rather than neurodegeneration
or severe malformation of nervous tissue. Reduced neuronal
branching and spine density have been observed in the visual and
somatosensory cortex (Della Sala et al., 2016; Pizzo et al., 2016),
and in the hippocampal region (Amendola et al., 2014; Fuchs
et al., 2014) of Cdkl5 KO mice. In addition, immunocytochemical
studies have demonstrated alterations in synaptic connectivity,
which might lead to an excitation-inhibition imbalance (Pizzo
et al., 2016; Sivilia et al., 2016). Together, these observations have
led to the suggestion that there is an overall reduction in the
number of synaptic inputs to neurons in the CDKL5-deficient
brain. It has been shown that CDKL5 is localized at excitatory
synapses (Ricciardi et al., 2012) where it binds to the scaffolding
postsynaptic density protein 95 (PSD-95) and to the synaptic
cell adhesion molecule NGL-1 (Ricciardi et al., 2012; Zhu et al.,
2013). Cdkl5 deficiency in primary hippocampal neurons leads
to deranged expression of the GluA2 subunit of alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid receptors (GluA2-
AMPAR), and it is probable that this prompts an alteration of
synaptic functions (Tramarin et al., 2018).
To date, only a few studies have investigated the functional
consequences of these changes at the synaptic level (Della Sala
et al., 2016; Okuda et al., 2017; Tang et al., 2017). Long-term
potentiation (LTP) is the most widely studied form of synaptic
plasticity in the mammalian nervous system. It provides a
neuronal substrate for learning and memory and is impaired in
several models of psychiatric and neurologic disorders. LTP was
found to be altered in opposing ways in two brain regions of
Cdkl5 KO mice: it was strongly reduced in the somatosensory
cortex (Della Sala et al., 2016) and slightly increased in the
hippocampal CA1 region (Okuda et al., 2017). The latter
effect appears to be mediated by upregulation of GluN2B-
containing NMDA receptors (Okuda et al., 2017). Interestingly,
the ablation of Cdkl5 expression specifically from forebrain
glutamatergic neurons leads to impairment in hippocampal
neuronal maturation, synaptic function, and impairment in
hippocampal-dependent learning and memory (Tang et al.,
2017). Despite this well-documented evidence, knowledge of the
molecular substrates underlying CDKL5-related alterations in
synaptic plasticity is still limited.
The perirhinal cortex (PRC) is located at the boundary
between the medial temporal lobe and the ventral visual pathway.
It has several interconnections with a wide range of cortical
and subcortical structures and is involved in various cognitive
processes. In particular, it plays an essential role in visual
recognition memory, that is critical to the ability to record events
and to guide prospective behavior (Kealy and Commins, 2011;
Suzuki and Naya, 2014; Brown and Banks, 2015). A previous
study has shown that male Cdkl5 KO mice tested in a sociability
protocol are more interested than littermate controls in a novel
object (Wang et al., 2012). This might suggest that visual
recognition memory is not affected by CDKL5 mutation, but
a novel object recognition (NOR) test is required to exclude
this possibility.
Perirhinal cortex has never been investigated in Cdkl5 KO
mice. Here we provide evidence for LTP impairment, associated
with reduced dendritic length, dendritic branches, PSD-95-
positive puncta, GluA2-AMPA receptor levels, and spine density
and maturation. Data obtained in a four-object NOR indicate
that also visual recognition memory is impaired. Notably, most of
these alterations, including LTP and visual recognition memory
impairments, were rescued by triggering the TrKB/PLCγ1
pathway using the 7,8-DHF prodrug R13.
MATERIALS AND METHODS
Colony
The mice were produced by crossing Cdkl5 KO +/− females
with Cdkl5 KO Y/− males (Amendola et al., 2014). Littermate
controls were used for all experiments. Animals were karyotyped
using PCR on genomic DNA as previously described (Amendola
et al., 2014). The day of birth was designated as postnatal day
(P) zero and animals with 24 h of age were considered as 1-day-
old animals (P1). Mice were housed three to five per cage on a
12-h light/dark cycle in a temperature-controlled environment
with food and water provided ad libitum. Experiments were
performed in accordance with the European Communities
Council Directive of 24 November 1986 (86/609/EEC) for the
use of experimental animals, and were approved by the Italian
Ministry of Public Health (approval n 114/2018-PR). All efforts
were made to minimize animal suffering and to keep the number
of animals used to a minimum.
Experimental Protocol
Experiments were carried out on a total of 85 Cdkl5 −/Y and
70 Cdkl5 +/Y mice. Treated Cdkl5 −/Y and Cdkl5 +/Y mice
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received a daily intraperitoneal injection (at 9–10 am) of R13
(7,8-DHF prodrug (Chen et al., 2018), 5.0 mg/kg in vehicle: PBS
with 1% DMSO) or vehicle from P35 to P50. The dosage of
5.0 mg/kg R13 (7,8-DHF) was chosen on the basis of previous
in vivo studies (Jang et al., 2010; Liu et al., 2010; Andero
et al., 2011, 2012; Devi and Ohno, 2012), which demonstrated
central TrkB activation enhanced neurogenesis and related
behavioral changes in rodents treated with systemic 7,8-DHF
administration. Intraperitoneal administration was chosen since
prolonged oral gavage administration was stressful and harmful
for Cdkl5 KO mice. At the end of the treatment, (P50) mice
were sacrificed for electrophysiological or histological analyses or
behavioral testing.
Electrophysiology
Preparation of horizontal brain slices (400 µm-thick, including
the PRC, the entorhinal cortex and the hippocampus),
electrophysiological recording of evoked field excitatory
postsynaptic potentials (fEPSP), measurements of fEPSP
amplitude and calculation of paired-pulse ratio (PPR) were
performed as previously reported (Ziakopoulos et al., 1999;
Aicardi et al., 2004; Roncacé et al., 2017) and are described in
detail in the online Supplementary Data. Theta burst stimulation
(TBS; four trains every 15 s, each train comprising 10 bursts of 5
pulses at 100 Hz, inter-burst interval 150 ms) (Ziakopoulos et al.,
1999) was used to induce LTP. Synaptic plasticity was further
investigated by delivering four consecutive TBS stimulations at
15-min intervals (Weng et al., 2011).
Immunohistochemistry
Some animals were deeply anesthetized and transcardially
perfused with ice cold phosphate-buffered saline (PBS, 100 mM,
pH 7.4), followed by a 4% solution of paraformaldehyde in PBS.
The right hemisphere was cut with a freezing microtome into
30 µm-thick coronal sections.
Synaptic Terminals
One out of four sections (3–6 per mouse) of the PRC
was used for immunohistochemistry. Free-floating sections
were stained overnight at 4◦C with the primary antibodies
post-synaptic density protein 95 (1:1000, anti-PSD-95 rabbit
polyclonal Ab, Abcam, Cambridge, United Kingdom) or
glutamate vesicular transporter 1 (1:500, anti-VGlut1 rabbit
polyclonal Ab, Thermo Scientific), and then stained in fluorescent
secondary antibody (Cy3-conjugated anti-rabbit secondary
antibody 1:200; Jackson ImmunoResearch Laboratories Inc.,
West Grove, PA, United States) for 2 h at room temperature.
For quantification of synaptic puncta, images immunoprocessed
for PSD-95 and VGlut1 were acquired with a Leica TCS SL
confocal microscope. In each section four images from the PRC
were captured and the density of individual puncta exhibiting
VGlut1 or PSD-95 immunoreactivity was evaluated as previously
described (Guidi et al., 2013).
P-PLCγ1 Intensity
Horizontal brain slices were cut from both hemispheres, and
LTP was induced in the PRC by TBS as described above
and in online Supplementary Data (Electrophysiology). Ten
minutes after TBS, the slices were fixed in a 4% solution
of paraformaldehyde in PBS, then cryoprotected in 15–20%
sucrose. Brain slices were cut using a freezing microtome
into 30 µm-thick transversal sections. Free-floating sections
were stained overnight at 4◦C with the primary antibodies
P-PLCγ1 (1:500, anti-P-PLCγ (Y783) rabbit polyclonal Ab,
Cell Signaling Technology, Danvers, MA, United States), and
then stained in fluorescent secondary antibody (Cy3-conjugated
anti-rabbit secondary antibody 1:200; Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, United States) for 2 h at
room temperature. Nuclei were counterstained with Hoechst-
33342 (Sigma-Aldrich) and fluorescence images were acquired
at the same intensity. To assess P-PLCγ1 cytoplasmic intensity a
cytoplasmic area was traced and the Cy3-staining corresponding
to the P-PLCγ1 signal was quantified by determining the
mean intensity of positive (bright) pixels inside this area.
The intensity of the cytoplasmic signal was normalized
to the background outside the same cell by calculating
the ratio between the intensity of cytoplasmic versus extra
cellular signal.
Golgi Staining
Golgi staining, measurement of the dendritic tree, and dendritic
spine analysis and calculation were performed as previously
reported (Guidi et al., 2013; Risher et al., 2014), and are described
in detail in the online Supplementary Data.
Western Blotting
In order to obtain samples of the PRC in isolation, it was micro-
dissected from slices (400 µm-thick) taken at the same levels as
those used for electrophysiological recording. In homogenates
of the PRC of P50 mice, total proteins were obtained as
previously described (Trazzi et al., 2011) and the antibodies
used are listed in Supplementary Table. For TrkB, PLCγ1,
and Erk phosphorylation levels, membranes were probed with
the antibody for the phosphorylated form of the analyzed
protein, stripped with the RestoreTM Stripping Buffer (Thermo
Fisher Scientific) following manufacturer’s instructions, and
then re-probed with the antibody for the un-phosphorylated
form of the same protein. Densitometric analysis of digitized
images was carried out with ChemiDoc XRS Imaging Systems
and Image LabTM Software (Bio-Rad Laboratories, Hercules,
CA, United States).
Behavioral Testing
The animal behavioral test was performed by operators blind to
genotype and treatment. Mice were allowed to habituate to the
testing room for at least 1 h before the test, and testing was always
performed at the same time of day. The test was performed in an
open field-arena (50 × 50 cm) and the behavior of the mice was
monitored using a video camera placed above the center of the
arena. The experiments were scored using EthoVision XT ver. 14
software (Noldus, Netherlands). Test chambers were cleaned with
70% ethanol between test subjects.
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Pretraining Habituation
The animals were habituated in the open field arena without
stimuli for 2 days before the commencement of the behavioral
testing. Each animal was placed in the center of the arena and
allowed to freely explore the open field for 20 min.
Novel Object Preference Task
The procedure involved a familiarization phase, followed by
a preference test phase (Supplementary Figure 1A). In the
familiarization phase (10 min duration), each animal was placed
in the same arena (of the pre-training habituation), in which
four copies of the same object (a plastic tube, too heavy for
the animal to displace; objects 1–4) were located near the four
corners of the arena (15 cm from each adjacent wall). After
1 h delay, during which one of the four objects (object 1)
was replaced by a novel object (a wooden cube; objects 2–
4 remained in the same positions), the animal was returned
to the arena for the preference test phase (10 min duration;
Supplementary Figure 1A).
Behavioral Measures
Exploration behavior was defined as the animal directing its nose
toward the object at a distance ≤ 2 cm or touching it with
the nose, while turning around or sitting on the object was not
considered as an exploration. Discrimination among the objects
was calculated using the Exploratory Preference Index, i.e., the
percentage of time spent exploring any of the four objects over
the total time spent exploring the four objects (Wang et al.,
2007). Therefore, a preference index of above 25% indicates the
preference for an object. Data obtained from the 10 min of the
test period are presented.
Statistical Analysis
Results are presented as the mean ± standard error of the
mean (SE). Statistical testing was performed using the two-tailed
Student’s t-test or two-way ANOVA with genotype (Cdkl5 −/Y,
Cdkl5 +/Y) and treatment (R13, vehicle) as factors, followed by
Fisher’s LSD or the Tukey post hoc test. For categorical data, that
is, percentages of spines, we used a chi-squared test. A probability
level of p < 0.05 was considered to be statistically significant.
RESULTS
LTP Is Impaired in the Perirhinal Cortex
of Cdkl5 KO Mice
To evaluate possible differences in PRC functional connectivity
between Cdkl5 −/Y and wild-type (+/Y) mice, we compared
fEPSPs evoked in layers II–III of the PRC by stimuli applied in
the same layers (Figure 1A). Stimulus-response curves (input-
output relationships) obtained from Cdkl5 −/Y slices were
not significantly different from those of wild-type mice over a
wide range of stimulus intensities (Figure 1B). Thus, the basic
properties of synaptic function in response to single stimuli
appear to be unaltered by Cdkl5 deletion. This conclusion is
strengthened by the observation that the slices from Cdkl5
−/Y and wild-type (+/Y) mice exhibited a similar relationship
between the magnitude of the afferent volley (“non-synaptic”
component of the response) and the magnitude of the synaptic
response (Figure 1C). Also the responses to paired stimuli
obtained in slices from Cdkl5 −/Y mice were not significantly
different from those of wild-type mice (Figure 1D), suggesting
that Cdkl5 deletion does not affect short-term synaptic plasticity.
To evaluate the possibility that Cdkl5 deletion may affect long-
term synaptic plasticity, we induced LTP in layers II–III of the
PRC using TBS, i.e., short trains of 100 Hz pulses delivered at
theta (5 Hz) frequency. We found that the magnitude of TBS-
induced LTP was significantly smaller in slices from Cdkl5 −/Y
mice (Figures 2A,B). Figure 2B shows that 55–60 min after TBS
the LTP magnitude was 165± 3.1% in slices from wild-type (+/Y)
mice, and only 139.0 ± 1.6% in slices from Cdkl5 −/Y mice.
Further investigation of synaptic plasticity was conducted by
delivering four consecutive TBS stimulations at 15-min intervals,
in order to reveal possible saturation effects. Figures 2C,D show
that the four TBS stimulations induced a significantly smaller
progressive increase of LTP magnitude in slices from Cdkl5 −/Y
mice compared to slices from wild-type (+/Y) mice, revealing a
saturation effect after the second stimulation (+/Y: 151.3± 2.1%,
180.8± 2.5%, 203.7± 3.3% and 221.4± 4.2%;−/Y: 131.7± 1.2%,
150.7 ± 1.8%, 153.6 ± 2.3% and 161.5 ± 3.3% of baseline
response; Figure 2D).
TrkB/PLCγ1 Signaling Is Impaired in the
Perirhinal Cortex of Cdkl5 KO Mice
A previous study in the PRC has shown that TBS elicits a large
increase in brain-derived neurotrophic factor (BDNF) secretion,
which is necessary for LTP induction (Aicardi et al., 2004). As
shown in Figure 3A, BDNF acts on TrkB receptors leading to
dimerization and autophosphorylation of tyrosine residues at
position Tyr515 and Tyr816. Phosphorylation and recruitment
of adaptors at position 515 activate Erk and Akt pathways, which
promote survival and growth of neurons and other cells through
Ras or GRB-associated binder G1 (GAB1). Phosphorylation at
position 816 recruits and activates phospholipase Cγ1 (PLCγ1),
which results in the generation of inositol-1,4,5-triphosphate
and diacylglycerol, leading to synaptic plasticity and dendritic
maturation (Minichiello et al., 2002; Gartner et al., 2006;
Minichiello, 2009).
To investigate the molecular mechanisms underlying TBS-
induced LTP impairment, we first analyzed the levels of TrkB
phosphorylation using Western blot in tissue homogenates
isolated from the PRC. Cdkl5−/Y mice showed no differences in
the P-TrkB(Tyr515) or total TrkB protein levels (Figures 3B,D).
On the contrary, we found a significantly lower level of
P-TrkB(Tyr816) protein in Cdkl5 −/Y mice compared to wild-
type (+/Y) mice (Figures 3B,D). No significant differences in
BDNF protein level were observed (Figures 3C,D), suggesting
a specific effect of Cdkl5 deletion on the autophosphorylation
process at position Tyr816 of TrkB, rather than on BDNF
availability. We then examined the main downstream effectors
of the TrkB pathway. Predictably, we found a significantly
lower PLCγ1 phosphorylation in the PRC of Cdkl5 KO
mice in comparison with wild-type mice, whereas no
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FIGURE 1 | Input-output relations and responses to paired-pulse stimulation in the perirhinal cortex (PRC) of Cdkl5 +/Y and Cdkl5 −/Y mice. (A) Example of the
response evoked in layers II/III of the PRC by stimulation of layers II/III. The double-headed arrows indicate how the magnitude of the presynaptic volley and synaptic
response were measured. (B) Magnitude of the synaptic response as a function of the stimulus strength in P50 Cdkl5 +/Y (n = 16; 10 animals) and Cdkl5 −/Y
(n = 21; 10 animals) mice. (C) Magnitude of the synaptic response as a function of the magnitude of the presynaptic volley. (D) Ratio of the synaptic responses
(R2/R1) evoked by a pair of stimuli with an interpulse interval of 200 ms in P50 Cdkl5 +/Y (n = 11; 9 animals) and Cdkl5 −/Y (n = 9; 9 animals) mice. Values represent
mean ± SE.
significant differences in Erk and Akt phosphorylation were
observed (Figures 3C,D).
Impaired PLCγ1 Phosphorylation and
LTP in the Perirhinal Cortex of Cdkl5 KO
Mice Are Rescued by Treatment With the
TrkB Agonist R13
In order to investigate whether TrkB/PLCγ1 signaling alteration
underlies LTP impairment in Cdkl5 KO mice, we quantified
P-PLCγ1 cellular intensity in PRC slices from Cdkl5 KO and
wild-type mice before and after TBS. Figures 4A–C show that
10 min after TBS, PLCγ1 phosphorylation was increased in PRC
slices from both Cdkl5 and wild-type mice. Interestingly, PLCγ1
phosphorylation after TBS was still significantly lower in Cdkl5
KO slices than in wild-type slices.
In order to investigate the effect of chronic activation of
TrkB/PLCγ1 signaling in Cdkl5 KO mice, we treated Cdkl5 −/Y
mice for 15 days with R13, a prodrug of 7,8-dihydroxyflavone
(7,8-DHF) (Chen et al., 2018). 7,8-DHF is a potent molecular
TrkB agonist that specifically binds to the TrkB receptor extra
cellular domain. A recent study in striatal neurons has shown that
it acts through selective phosphorylation of the 816 residue of
TrkB, leading to activation of the PLCγ1 pathway (Garcia-Diaz
Barriga et al., 2017). Accordingly, we found that R13 treatment
increased PLCγ1 phosphorylation levels but not P-Erk levels in
both Cdkl5 and wild-type mice (Figures 4D,E), suggesting a
selective action of 7,8-DHF on the TrkB(Y816)-PLCγ1 pathway
also in the PRC.
Interestingly, R13 treatment restored LTP in Cdkl5 −/Y
mice (Figures 5A–D), suggesting a critical role of TrkB/PLCγ1
signaling in the defective synaptic plasticity. R13 treatment
affected neither LTP in Cdkl5 +/Y mice (Figures 5A–D)
nor basal synaptic transmission (input-output responses;
responses to paired stimuli) in Cdkl5 −/Y and Cdkl5 +/Y
mice (not shown). Vehicle treatment did not affect any
functional parameter considered in Cdkl5 −/Y and Cdkl5 +/Y
mice (Figures 5A–D).
Alteration of Dendritic Pattern in the
Perirhinal Cortex of Cdkl5 KO Mice Is
Rescued by Treatment With the TrkB
Agonist R13
BDNF/TrkB signaling participates in the regulation of dendritic
differentiation, and in the formation and maturation of dendritic
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FIGURE 2 | LTP in the perirhinal cortex of Cdkl5 +/Y and Cdkl5 −/Y mice. (A) Amplitude of the synaptic responses evoked before and after theta burst stimulation
(TBS; four trains every 15 s, each train comprising 10 bursts of 5 pulses at 100 Hz, inter-burst interval 150 ms). Here and in the following panels (B–D), the amplitude
of the responses is expressed as a percentage of the average amplitude of responses recorded 10 min before LTP induction. Here, and in panel C, the arrows
indicate the time of delivery of the TBS. The traces at the top are examples of responses recorded before, and 55–60 min after, LTP induction. (B) The histograms
indicate the averaged amplitude of the responses recorded 55–60 min after TBS. Same data as in (A). Recordings were carried out in slices from P50 Cdkl5 +/Y
(n = 9; 5 animals) and Cdkl5 −/Y (n = 11; 9 animals) mice. (C) Amplitude of the synaptic response evoked before and after four consecutive TBS stimulations
delivered at 15-min intervals. (D) The histograms indicate the averaged amplitude of the responses recorded 10–15 min after each TBS. Same data as in (C).
Recordings were carried out in slices from P50 Cdkl5 +/Y (n = 7; 7 animals) and Cdkl5 −/Y (n = 7; 7 animals) mice. ∗∗∗p < 0.001 (Student’s two-tailed t-test).
spines during postnatal development (Chapleau et al., 2009).
Abnormalities in dendritic and synaptic differentiation are
thought to underlie altered synaptic function and network
connectivity, thus contributing to the impaired neuronal
function. Previous studies in Cdkl5 −/Y mice have shown
a reduction in dendritic pattern in granule cells and CA1
pyramidal neurons of the hippocampal region (Fuchs et al., 2015;
Trazzi et al., 2016).
In order to establish whether these alterations also occur in
PRC neurons, we examined apical and basal dendritic branches
of layer II-III PRC neurons in Golgi-stained brain sections
(Figure 6A). We found that both basal and apical dendrites were
shorter (Figure 6B), and there was a reduced number of branches
(Figure 6C) in PRC neurons of Cdkl5 −/Y compared to Cdkl5
+/Y mice. Interestingly, R13 treatment restored dendritic length
and number of branches in Cdkl5 −/Y mice, but had no effect
in control mice (+/Y) (Figures 6B,C). Figure 6D shows that the
difference in number of branches was significant in the fourth and
fifth order in apical dendrites, and in the second, third, and fourth
order in basal dendrites; moreover, it shows a lack of branches
of the seventh order in basal dendrites. All these defects were
corrected by R13 treatment. These results indicate that activation
of the TrkB/PLCγ1 pathway restores the dendritic pattern of
the PRC neurons in Cdkl5 −/Y mice. Vehicle treatment did not
affect any morphological parameter considered in Cdkl5−/Y and
Cdkl5+/Y mice (Figures 6B–D).
Alteration of Dendritic Spine Density in
the Perirhinal Cortex of Cdkl5 KO Mice Is
Rescued by Treatment With the TrkB
Agonist R13
In Golgi-stained brain sections we examined spine density in
the apical and basal dendritic branches of layer II-III neurons
of the PRC. PRC neurons had a reduced spine density in both
basal and apical dendrites in untreated Cdkl5 −/Y mice in
comparison with wild-type (+/Y) mice (Figures 7A,B). Cdkl5
−/Y mice treated with R13 underwent a restoration of spine
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FIGURE 3 | TrkB signaling pathways in the perirhinal cortex of Cdkl5 +/Y and Cdkl5 −/Y mice. (A) Diagram of brain-derived neurotrophic factor (BDNF) and TrkB
signaling pathways. BDNF binds to the extra cellular domain of TrkB forming homodimers to activate downstream intracellular signaling cascades, including Shc/Erk,
Shc/Akt, and phospholipase C (PLC) γ1 pathways. (B) Western blots examples of P-TrkB (Tyr816 and Tyr515) and TrkB in PRC homogenates of P50 Cdkl5 +/Y and
Cdkl5 −/Y mice. (C) Western blot examples of BDNF, P-PLCγ1 (Tyr783), PLCγ1, P-Erk, Erk, P-Akt (Ser437), Akt and GAPDH levels in PRC homogenates of P50
Cdkl5 +/Y and Cdkl5 −/Y mice. (D) The histograms show western blot analysis of samples as in B,C. Phosphoprotein levels were normalized to corresponding
(Continued)
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FIGURE 3 | Continued
total protein levels, and total protein levels were normalized to GAPDH (Cdkl5 +/Y n = 5; Cdkl5 +/Y n = 5). Data are expressed as % of those obtained in Cdkl5 +/Y
mice. Values represent mean ± SE. ∗p < 0.05 (Student’s two-tailed t-test).
FIGURE 4 | Effect of TBS or treatment with R13 on TrkB/ PLCγ1 signaling in the perirhinal cortex of Cdkl5 −/Y mice. (A) Quantification of P-PLCγ1 signal intensity in
PRC slices before and after theta burst stimulation (TBS; four trains every 15 s, each train comprising 10 bursts of 5 pulses at 100 Hz, inter-burst interval 150 ms) of
Cdkl5 +/Y (n = 4) and Cdkl5 −/Y (n = 4) mice. (B) A representative image of PRC processed for fluorescent P-PLCγ1 immunostaining (red) of a wild-type (+/Y)
mouse. Nuclei are stained with Hoechst (blue). The dotted box indicates the region shown at a higher magnification in (C). Scale bar = 50 µm. Roman numerals
indicate PRC cytoarchitectonic layers. (C) Representative images of layer II-III PRC neurons of Cdkl5 +/Y and Cdkl5 −/Y PRC slices as in (A). (D,E) Quantification of
PLCγ1 and Erk phosphorylation levels before and after treatment with R13. Cdkl5 −/Y and Cdkl5 +/Y mice were treated for 15 days (5 mg/Kg IP) from postnatal day
35 (P35) to 50 (P50), the day of sacrifice. Western blot examples (D) and analyses (E) of P-PLCγ1 (Tyr783), PLCγ1, P-Erk and Erk levels in PRC homogenates of
vehicle-treated Cdkl5 +/Y (n = 5) and Cdkl5 −/Y (n = 5) mice, and R13-treated Cdkl5 +/Y (n = 6) and Cdkl5 −/Y (n = 6) mice. Values represent mean ± SE.
∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 (Fisher’s LSD test after two-way ANOVA).
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FIGURE 5 | Effect of treatment with R13 on LTP in the perirhinal cortex of Cdkl5 −/Y mice. (A) Amplitude of the synaptic responses evoked before and after TBS.
Here, and in the following panels (B–D), the amplitude of the responses is expressed as a percentage of the average amplitude of responses recorded 10 min before
TBS. The traces at the top are examples of responses recorded before, and 55–60 min after, TBS. Here, and in panel C, the arrows indicate the time of TBS delivery.
Recordings were carried out in slices from P50 vehicle-treated Cdkl5 +/Y (n = 13; 7 animals) and Cdkl5 −/Y (n = 13; 6 animals), and R13-treated Cdkl5 +/Y (n = 6; 4
animals) and Cdkl5 −/Y (n = 7; 7 animals) mice. (B) The histograms indicate the averaged amplitude of the responses recorded 55–60 min after TBS. Same data as
in (A). (C) Amplitude of the synaptic responses evoked before and after four consecutive TBS stimulations delivered at 15-min intervals. Recordings were carried out
in slices from P50 vehicle-treated Cdkl5 +/Y (n = 6; 6 animals) and Cdkl5 −/Y (n = 7; 7 animals), and R13-treated Cdkl5 +/Y (n = 7; 4 animals) and Cdkl5 −/Y (n = 6;
6 animals) mice. (D) The histograms indicate the averaged amplitude of the responses recorded 10–15 min after each TBS. Same data as in (C). Values represent
mean ± SE. ∗p < 0.05; ∗∗p < 0.01 (Tukey test after two-way ANOVA).
density (Figures 7A,B). Dendritic spines are heterogeneous
in size and shape, and can be classified as immature spines
(filopodia, thin-shaped, and stubby-shaped) and mature spines
(mushroom and cup shapes) (Risher et al., 2014). Separate
counts of different classes of dendritic spines revealed that
PRC neurons of Cdkl5 −/Y mice had a higher percentage of
immature spines and a reduced percentage of mature spines
compared to Cdkl5 +/Y mice (Figure 7C). Treatment with R13
improved the balance between immature and mature spines
(Figure 7C), suggesting that activation of the TrkB/PLCγ1
pathway improves PRC dendritic spine maturation. Vehicle
treatment did not affect spine density in Cdkl5 −/Y and Cdkl5
+/Y mice (Figures 7A,B).
Altered Expression of PSD-95 Positive
Synaptic Puncta and GluA2-AMPAR in
the Perirhinal Cortex of Cdkl5 KO Mice Is
Rescued by Treatment With the TrkB
Agonist R13
Most excitatory synapses in the mature mammalian brain occur
on spines in which postsynaptic density protein 95 (PSD-95)
clusters are localized. Evaluation of PSD-95 immunoreactivity
showed a strong reduction in the number of PSD-95-positive
puncta in the PRC of Cdkl5 −/Y mice (Figures 8A,B), which is
consistent with the reduced number of mature spines (Figure 7C)
and suggests loss of excitatory synaptic contacts. To clarify
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FIGURE 6 | Effect of treatment with R13 on dendritic morphology in the perirhinal cortex of Cdkl5 −/Y mice. (A) Example of Golgi-stained section at the level of the
PRC of a P50 Cdkl5 −/Y mouse (panel on the left; scale bar = 100 µm). The central panel shows a higher magnification of the area enclosed in the red square.
Roman numerals indicate PRC cytoarchitectonic layers. The panel on the right shows an example of the apical and basal dendritic tree of a Golgi-stained PRC
neuron from layers II-III (scale bar = 30 µm). (B) Apical and basal mean total dendritic length of layer II-III PRC neurons of vehicle-treated P50 Cdkl5 +/Y (n = 4) and
Cdkl5 −/Y (n = 4) mice, and R13-treated P50 Cdkl5 +/Y (n = 4) and Cdkl5 −/Y (n = 5) mice. (C) Mean number of dendritic segments of the apical and basal
dendrites of layer II-III PRC neurons in the same mice as in (B). (D) Mean number of apical and basal branches of the different orders of vehicle-treated Cdkl5 +/Y
(n = 4) and Cdkl5 −/Y (n = 4) mice, and R13-treated Cdkl5 −/Y (n = 5) mice. The numbers on the X axis indicate the branch order. The arrow indicates the absence
of branches in Cdkl5 −/Y mice. Values in (B–D) represent mean ± SE. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 (Fisher’s LSD test after two-way ANOVA).
this issue, we examined the immunoreactivity for the vesicular
glutamate transporter-1 (VGlut1), a marker of glutamatergic
(excitatory) terminals. We found no difference in the number of
VGlut1-positive immunoreactive puncta between Cdkl5−/Y and
wild-type mice (Figures 8A,C), indicating a similar number of
glutamatergic terminals in the PRC. Treatment with R13 restored
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FIGURE 7 | Effect of treatment with R13 on dendritic spines in the perirhinal
cortex of Cdkl5 −/Y mice. (A) Images of Golgi-stained dendritic branches of
layer II-III perirhinal neurons of a P50 Cdkl5 +/Y and a Cdkl5 −/Y mouse, and
of a Cdkl5 −/Y mouse treated with R13. Scale bar = 1.5 µm. (B) Dendritic
spine density (number of spines per 10 µm) in apical and basal dendrites from
vehicle-treated Cdkl5 +/Y (n = 4) and Cdkl5 −/Y (n = 4) mice, and Cdkl5 +/Y
(n = 4) and Cdkl5 −/Y (n = 4) mice treated with R13. (C) Percentage of
immature and mature spines in relation to the total number of protrusions of
layer II-III perirhinal neurons in mice as in (B). Values represent mean ± SE.
∗∗P < 0.01; ∗∗∗P < 0.001; #p < 0.01 compared to untreated Cdkl5 −/Y mice
in (C) [data in (B) Fisher’s LSD test after two-way ANOVA; data in
(C) Chi-squared test].
the number of PSD-95-positive immunoreactive puncta in Cdkl5
−/Y mice, but did not affect immunoreactivity for PSD-95 in
Cdkl5 +/Y mice (Figures 8A,B) or for VGlut1 in Cdkl5 +/Y and
Cdkl5−/Y mice (Figures 8A,C). Vehicle treatment did not affect
immunoreactivity for PSD-95 or VGlut1 in Cdkl5+/Y and Cdkl5
−/Y mice (Figures 8A,C).
The TrkB/PLCγ1 pathway is involved in diverse postsynaptic
events, such as the modulation of AMPAR expression and
trafficking, which in turn contributes to synaptic plasticity
(Jang et al., 2013). As previously observed in hippocampal
neurons (Tramarin et al., 2018), we found a lower expression
of GluA2-AMPAR in the PRC of Cdkl5 −/Y mice in
comparison with wild-type mice (Figures 8D,E). Notably,
GluA2-AMPAR levels in Cdkl5 −/Y mice were rescued by
treatment with R13 (Figures 8D,E).
FIGURE 8 | Effect of treatment with R13 on neuronal connectivity in the
perirhinal cortex of Cdkl5 −/Y mice. (A) Representative fluorescence image of
a PRC section processed for PSD-95 or VGlut1 immunoreactivity, showing
examples of PSD-95 and VGlut1 immunoreactive puncta. Scale bar: 3 µm.
(B,C) Number of fluorescent puncta per µm2 exhibiting PSD-95 (B) or VGlut1
(C) immunoreactivity in layers II-III of the PRC of vehicle-treated P50 Cdkl5
+/Y (n = 4) and Cdkl5 −/Y (n = 4) mice, and P50 Cdkl5 +/Y (n = 4) and Cdkl5
−/Y (n = 4) mice treated with R13. (D,E) Western blot analysis of
GluA2-AMPA levels in PRC homogenates of vehicle-treated P50 Cdkl5 +/Y
(n = 6) and Cdkl5 −/Y (n = 6) mice and R13-treated P50 Cdkl5 −/Y (n = 5)
mice. Values represent mean ± SE. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001
(data in (B,C) Fisher’s LSD test after two-way ANOVA; data in (E) Student’s
two-tailed t-test).
Altered Visual Recognition Memory in
Cdkl5 KO Mice Is Rescued by Treatment
With the TrkB Agonist R13
In the rodent brain, PRC plays an essential role in visual
object recognition memory, that can be evaluated using the
NOR test. A 4-object NOR test was performed in an open-field
arena, preceded by a 2-day habituation phase (Supplementary
Figure 1A). During the familiarization phase, animals normally
show equal preference for the objects that are placed in an arena,
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while they exhibit a higher preference for the new object during
the subsequent test phase. Discrimination among the objects
(Preference Index) was calculated by taking into account the
percentage of time spent exploring any of the four objects over the
total time spent exploring the objects. As expected, the preference
index in wild-type (+/Y) mice was significantly larger for the
novel object during the test phase (Figures 9A,B). However,
we did not observe any increase in preference index in Cdkl5
−/Y mice (Figure 9B), indicating a deficit in remembering the
identity of an object in an open field. Interestingly, treatment
with R13 rescued visual recognition memory in Cdkl5 −/Y mice
(Figure 9B). R13 treatment did not affect locomotor activity in
Cdkl5 −/Y or Cdkl5 +/Y mice (Supplementary Figure 1B); nor
FIGURE 9 | Effect of treatment with R13 on novel object recognition memory
in Cdkl5 -/Y mice. (A) Familiarization phase. Percentage of time spent
exploring the four identical objects during the familiarization phase (10 min
duration) of vehicle-treated Cdkl5 −/Y (n = 13) and Cdkl5 +/Y (n = 13) mice,
and R13-treated Cdkl5 −/Y (n = 9) and Cdkl5 +/Y (n = 9) mice.
(B) Exploratory Preference Test phase (one hour after the familiarization
phase, 10 min duration). Percentage of time spent exploring new object 1
(that replaced the previous object 1) and the previous identical objects 2–4.
Same mice as in (A). Values represent mean ± SE. ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001 (Fisher’s LSD test after two-way ANOVA).




Impairments in the Perirhinal Cortex of
Cdkl5 KO Mice
Our results indicate that the magnitude of LTP is reduced in the
PRC of Cdkl5 KO mice, consistently with the strong reduction
previously observed in the somatosensory cortex (Della Sala
et al., 2016). To investigate the molecular mechanisms underlying
LTP reduction, we analyzed some elements of the signaling
cascade activated by BDNF. Previous studies in the hippocampus
have shown that the PLCγ1 pathway mediated by TrkB plays a
predominant role in LTP (Minichiello et al., 2002), whereas the
Erk/Akt pathway is of lesser, if of any, importance (Korte et al.,
2000). Accordingly, we found a lower PLCγ1 phosphorylation in
the PRC of Cdkl5 KO mice in comparison with wild-type mice,
and no significant differences in Erk and Akt phosphorylation.
This evidence suggests that the TrkB/PLCγ1 pathway plays a
critical role in the observed alteration of LTP in the PRC.
Brain-derived neurotrophic factor levels were not reduced in
Cdkl5 KO mice, suggesting a specific effect of Cdkl5 deletion on
the autophosphorylation process at position Tyr816, rather than
on BDNF availability.
At variance with the results obtained in the PRC (present
data) and somatosensory cortex (Della Sala et al., 2016), LTP was
previously found to be slightly increased in the hippocampal CA1
region of Cdkl5 KO mice (Okuda et al., 2017), suggesting that
CDKL5 action might be region-specific. These conflicting results
might also be explained, at least in part, by different sensitivity to
LTP inducing protocols, TBS [present data, and (Della Sala et al.,
2016)] versus HFS (Okuda et al., 2017).
Previous studies in Cdkl5 KO mice have shown reduced
neuronal branching accompanied by reduced spine density
and maturation in the hippocampus, in the visual cortex,
and in the somatosensory cortex (Amendola et al., 2014;
Fuchs et al., 2014; Della Sala et al., 2016; Pizzo et al., 2016;
Trazzi et al., 2016). Accordingly, we found that PRC neurons
of Cdkl5 KO mice are characterized by a shorter dendritic
length, a reduced number of branches, a lower spine density
and a higher percentage of immature spines. Moreover, we
observed a reduced number of PSD-95 immunoreactive puncta
in dendritic spines. Since PSD-95 localization in the spine
correlates with activity-driven synapse stabilization (Ehrlich
et al., 2007), the decreased number of PSD-95 puncta in Cdkl5
KO mice correlates with the observed increased number of
immature spines. Evaluation of the number of presynaptic
excitatory terminals (VGlut1 immunopositive puncta) showed
no difference between Cdkl5 KO and wild-type mice, in
accordance with the observation that basic properties of synaptic
function are unaltered in the PRC (present data) and in the
hippocampus (Okuda et al., 2017). As observed in hippocampal
neurons (Tramarin et al., 2018), we found a lower expression
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of GluA2-AMPAR in the PRC of Cdkl5 −/Y mice. Most
neuronal AMPARs contain this critical subunit, but in certain
restricted neuronal populations and under certain physiological
or pathological conditions, AMPARs that lack this subunit
are expressed. This subunit determines many of the major
biophysical properties of AMPARs (including Ca2+ permeability,
single-channel conductance, and receptor kinetics), strongly
influences receptor assembly and trafficking, and plays pivotal
roles in various forms of synaptic plasticity (Isaac et al., 2007).
In particular, GluA2-AMPAR is required for spine changes
during synaptic plasticity (Asrar and Jia, 2013). Thus, it is
reasonable to suppose that the lower expression of GluA2-
AMPAR in the PRC might play a role in the impaired functional
and morphological synaptic plasticity observed in the PRC of
Cdkl5−/Y mice.
Visual recognition memory is the ability to judge the prior
occurrence of stimuli and is fundamental to our ability to
record events and to guide prospective behavior. Studies in
humans and animals indicate that PRC plays an essential
role in recognition memory and familiarity discrimination
for individual items (Kealy and Commins, 2011; Suzuki and
Naya, 2014; Brown and Banks, 2015). Our finding that short-
term object recognition memory is impaired in Cdkl5 KO
mice is in line with the observed neuroanatomical defects
and LTP impairment in the PRC. This behavioral evidence
suggests that specific PRC defects may contribute, along with
hippocampal impairments, to poor memory performance in
individuals with CDD.
Treatment With the TrkB Agonist R13
Rescues Functional and Morphological
Impairments in the Perirhinal Cortex of
Cdkl5 KO Mice
The natural flavonoid 7,8-DHF, a potent small molecular TrkB
agonist, displays beneficial effects on the brain in health and
disease (Spencer, 2008; Williams and Spencer, 2012; Roncacé
et al., 2017), but has only modest oral bioavailability and
a moderate pharmacokinetic profile. To efficiently mimic the
actions of BDNF, we used the recently synthesized 7,8-DHF
prodrug R13, which is hydrolyzed into 7,8-DHF in liver
microsomes and is characterized by a longer half-life and a
higher plasma concentration, and higher brain exposure (Chen
et al., 2018). We found that treatment with R13 activated
TrkB/PLCγ1 signaling, rescued the impaired TBS-induced LTP,
restored dendritic pattern as well as PSD-95 and GluA2-
AMPAR levels, and improved the balance between immature and
mature spines in PRC neurons of Cdkl5 KO mice. Importantly,
restoration of morphological and synaptic impairments leaded
to recovery of PRC-dependent visual recognition memory in
Cdkl5 KO mice.
In wild type +/Y mice, treatment with R13 caused an
activation of TrkB/PLCγ1 signaling in the PRC (Figure 4D),
which, however, did not induce effects on PRC neuroanatomy
or synaptic function and, consequently, on behavior. The
finding that treatment with R13 has relatively scarce or
no effects in normal animals is in line with a previous
evidence (Garcia-Diaz Barriga et al., 2017) and suggests that
TrkB/PLCγ1 signaling activation may help brain development
under abnormal, but not normal, brain conditions.
Indeed, an increasing body of evidence suggests that PLCγ1
plays a pivotal role in the regulation of synaptic plasticity
and maturation; in particular, PLCγ1 signaling is required
for structural and functional changes in spine actin, PSD
scaffolding, and AMPAR trafficking (Horne and Dell’Acqua,
2007). Consistent with its critical role, abnormal expression and
activation of PLCγ1 has been observed in various brain disorders
(Jang et al., 2013).
CONCLUSION
In conclusion, present results provide the first evidence for
morphological and functional impairments in the PRC of Cdkl5
KO mice, associated with a deficit in visual recognition memory.
The TrkB agonist R13 rescued most of these alterations, including
LTP and visual recognition memory impairments, by triggering
the TrkB/PLCγ1 pathway. If R13 induced a widespread positive
effect in other brain areas, it might represent a promising
candidate for a targeted therapeutic strategy aimed at restoring
synaptic development and plasticity in CDD patients.
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